Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1mg/kg + ipilimumab 3mg/kg expansion from CheckMate 032
Saved in:
| Published in | Annals of oncology Vol. 29; p. viii725 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
01.10.2018
|
| Online Access | Get full text |
Cover
Loading…
| Author | Callahan, M. Bono, P. Ascierto, P.A. Morse, M. Lopez-Martin, J.A. Brossart, P. Meadows-Shropshire, S. Sharma, P. Basso, U. Calvo, E. Rohrberg, K.S. Rosenberg, J.E. Siefker-Radtke, A.O. de Braud, F.G.M. Lin, W.H. Saci, A. Reguart, N. |
|---|---|
| Author_xml | – sequence: 1 givenname: J.E. surname: Rosenberg fullname: Rosenberg, J.E. organization: Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA – sequence: 2 givenname: P. surname: Sharma fullname: Sharma, P. organization: Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA – sequence: 3 givenname: F.G.M. surname: de Braud fullname: de Braud, F.G.M. organization: Medical Oncology & Haematology, Istituto Nazionale dei Tumori, Milan, Italy – sequence: 4 givenname: U. surname: Basso fullname: Basso, U. organization: Medical Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy – sequence: 5 givenname: E. surname: Calvo fullname: Calvo, E. organization: START Madrid- CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain – sequence: 6 givenname: P. surname: Bono fullname: Bono, P. organization: Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland – sequence: 7 givenname: M. surname: Morse fullname: Morse, M. organization: Medical Oncology, Duke University Medical Center, Durham, NC, USA – sequence: 8 givenname: P.A. surname: Ascierto fullname: Ascierto, P.A. organization: Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy – sequence: 9 givenname: J.A. surname: Lopez-Martin fullname: Lopez-Martin, J.A. organization: Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain – sequence: 10 givenname: P. surname: Brossart fullname: Brossart, P. organization: Hematology-Oncology, University Hospital of Bonn, Bonn, Germany – sequence: 11 givenname: K.S. surname: Rohrberg fullname: Rohrberg, K.S. organization: Oncology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark – sequence: 12 givenname: N. surname: Reguart fullname: Reguart, N. organization: Oncology, Hospital Clinic of Barcelona, Barcelona, Spain – sequence: 13 givenname: W.H. surname: Lin fullname: Lin, W.H. organization: BMS Clinical, Bristol Myers Squibb, Princeton, NJ, USA – sequence: 14 givenname: S. surname: Meadows-Shropshire fullname: Meadows-Shropshire, S. organization: Global Biometric Sciences, Bristol-Myers Squibb, Princeton, NJ, USA – sequence: 15 givenname: A. surname: Saci fullname: Saci, A. organization: Clinical Biomarkers, Bristol-Myers Squibb, Princeton, NJ, USA – sequence: 16 givenname: M. surname: Callahan fullname: Callahan, M. organization: Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA – sequence: 17 givenname: A.O. surname: Siefker-Radtke fullname: Siefker-Radtke, A.O. organization: Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32138000$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkc1u3CAUhVGUqpkkfYBsIpYzap3BBjxGWVWj_kRK002yRhiuZ0gMWBhPm2fty5SR26psEIdP9x6dc45OffCA0FVJbkoi6Fr5LOi1M6-sYjeENidoUfJaFA1h5SlaEFHRYsMpO0Pn4_hMCKlFJd6iM1qVtMnPBfr1YA-hn5xq8fJhhVWfN-AQsfVYB9dar5INHv-waY_tYHvrZvZudUSG_As-jXg5pHE1U0OfRT-5YoiQIqgEBjtIakxZ13iKIe2ht6rHWkVtfXAKL93TdvUhT9T9ZKzf4Yxg_89Z6Xbrlx1-_78DOmvwc1B-PFrsYnB4uwf98i3vxIRWl-hNp_oR3v25L9DT50-P26_F_fcvd9uP9wWUjKeirhSHHBvdsKatBROGN4LwzvANqzSnLWsMB8GNYEwJ2OTDDKlJ3XSdYtzQC3Q9zx2m1oGRQ7ROxVf5N-UM3M4AZBcHC1GOOuemwdgIOkkTrCyJPHYq507l3KnMndLf3vGZYQ |
| ContentType | Journal Article |
| Copyright | 2018 THE AUTHORS |
| Copyright_xml | – notice: 2018 THE AUTHORS |
| DBID | 6I. AAFTH NPM |
| DOI | 10.1093/annonc/mdy424.038 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed |
| DatabaseTitle | PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1569-8041 |
| EndPage | viii725 |
| ExternalDocumentID | 32138000 S092375341950429X |
| Genre | Journal Article |
| GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6I. 6J9 70D AABJS AABMN AAEDW AAESY AAFTH AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 0SF AALRI ADVLN AEHUL AFETI AFJKZ AFSHK AKRWK H13 NPM |
| ID | FETCH-LOGICAL-e145t-62a5e1563748b6949d58905fd5742c53b48d5e95d944a9e77774d06068ffa45d3 |
| IEDL.DBID | ABVKL |
| ISSN | 0923-7534 |
| IngestDate | Wed Oct 16 00:46:55 EDT 2024 Fri Feb 23 02:48:13 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | http://www.elsevier.com/open-access/userlicense/1.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-e145t-62a5e1563748b6949d58905fd5742c53b48d5e95d944a9e77774d06068ffa45d3 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S092375341950429X |
| PMID | 32138000 |
| ParticipantIDs | pubmed_primary_32138000 elsevier_sciencedirect_doi_10_1093_annonc_mdy424_038 |
| PublicationCentury | 2000 |
| PublicationDate | October 2018 2018-Oct |
| PublicationDateYYYYMMDD | 2018-10-01 |
| PublicationDate_xml | – month: 10 year: 2018 text: October 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Annals of oncology |
| PublicationTitleAlternate | Ann Oncol |
| PublicationYear | 2018 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| SSID | ssj0006929 |
| Score | 2.3601272 |
| SourceID | pubmed elsevier |
| SourceType | Index Database Publisher |
| StartPage | viii725 |
| Title | Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1mg/kg + ipilimumab 3mg/kg expansion from CheckMate 032 |
| URI | https://dx.doi.org/10.1093/annonc/mdy424.038 https://www.ncbi.nlm.nih.gov/pubmed/32138000 |
| Volume | 29 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELb2ISEuiPc-YDUHDq3A1IntND4uFcvyaC9Q1FvkOM4SbZNG3VSC38qfYaZOV4u4kaM1SRzP5PM3tmeGsVfjpIil1SkvtFScEnjxHNXOC6NKbdNSJtuU-dNZcjlXnxZ6sccmu1gYOlbZY3_A9C1a9y2jfjRHbVWNvgrkJki2FRUyRVRd7LPDGNkv_p2H5---f_5yC8iJiUPKvVhyumG3uWkk1XpZNQ6d_18qVm8FRan8OyfdmXAuHrIHPVOE89CZR2zPN4_ZvWm_F_6E_Z5VW2ixOQxmQ7DLVeNhtYaqAfwYdHi3Yw600ApVWy2rOsh-HJJIn0_1BgZtdzMMUi2di2s2NadDiEQmfQG17ywFHVUONmuK1lqiwYKjCkTNqrYwqOeT4Rt8oltuaBoEFIHmtmdRfTW6voLXd3sgQ5v_iUBEa3VAIS4w-eHd9RTfCULGT9n84v23ySXvSzVwHynd8SS22qMrSMls8sQoU-jUCF0WGl1vp2Wu0kJ7o9EElDV-jJcqBDpPaVlapQv5jB2gJvwRA-WkjnInDSKJEm5scjtGWhMJp6TwSXLM1E5D2V-WkuEkkIU9dZkFxWZBsRkq9pg9D9rM2pDGI5NxJJEui5P_e-Apu4_kKeTGjV6wg2698S-RoHT5WW-AZ2z_wyL6A3d952E |
| link.rule.ids | 315,783,787,27581,27936,27937,45675 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELZGJ8Fe0Pi9MeAeeGgFoU5sJ_HjqJg61vaFFfXNchxnRGvSqEsl9rfun-Fcp9MQb-TRchzHd_ruO9t3R8jHJM4jpkUa5ILxwCXwCjIUe5BLXgidFizepsyfzuLxnH9fiMUeGe1iYdy1yg77PaZv0bprGXarOWzKcviDIjdBss1dIVNE1cUjso9sIBE9sn_69efF5B6QYxn5lHsRC9wLu8NNyVytl1Vt0Pm_5RH_Ql2Uyr826YHBOTskTzumCKd-Ms_Inq2fk8fT7iz8BbmblVto0Rn0ZwPQy1VtYbWGsgb8GXR4t2sObqMVyqZclpXvez5wXbp8qjfQb9qbge_VuHtx9aYK3CVERyZtDpVttQs6Kg1s1i5aa4kKC8ZVIKpXlYZ-NR8NPuOIZrlxZhCwC9T3Mwurq-H1FXx6OAPm2-xvBCK3VwcuxAVGv6y5nuI3gbLoJZmffbscjYOuVENgQy7aII60sOgKumQ2WSy5zEUqqShyga63ESzjaS6sFKgCXEub4MNzis5TWhSai5y9Ij2UhH1DgBsmwswwiUjCqUlkphOkNSE1nFEbx0eE7ySk_tIUhUZA-TN1prxglResQsEekddemqrxaTwUi0KGdJke_9-AH8iT8eV0oibns4u35ACJlM-TG56QXrve2HdIVtrsfaeMfwAGHule |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nivolumab+%28N%29+alone+or+in+combination+with+ipilimumab+%28I%29+in+patients+%28pts%29+with+platinum-pretreated+metastatic+urothelial+carcinoma+%28mUC%29%2C+including+the+nivolumab+1mg%2Fkg+%2B+ipilimumab+3mg%2Fkg+expansion+from+CheckMate+032&rft.jtitle=Annals+of+oncology&rft.au=Rosenberg%2C+J+E&rft.au=Sharma%2C+P&rft.au=de+Braud%2C+F+G+M&rft.au=Basso%2C+U&rft.date=2018-10-01&rft.eissn=1569-8041&rft.volume=29+Suppl+8&rft.spage=viii725&rft_id=info:doi/10.1093%2Fannonc%2Fmdy424.038&rft_id=info%3Apmid%2F32138000&rft.externalDocID=32138000 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |